Form 4: Nu Skin Director Mark Zorko Granted Over 18,000 Shares of Class A Common Stock

Nu Skin Enterprises, Inc. Director Mark A. Zorko was granted 18,008 shares of Class A Common Stock at no cost, increasing his direct beneficial ownership to 33,943 shares.

Summary

• Mark A. Zorko, a Director of Nu Skin Enterprises, Inc. (NUS), acquired 18,008 shares of Class A Common Stock.
• The transaction occurred on June 2, 2025, and the shares were acquired at a price of $0.00, indicating a grant or award rather than a purchase.
• Following this transaction, Mr. Zorko directly beneficially owns a total of 33,943 shares of Nu Skin Enterprises, Inc. Class A Common Stock.
• The filing also includes a Limited Power of Attorney, dated June 3, 2025, authorizing several individuals, including Gregory Belliston, to act on behalf of Mark Zorko for SEC reporting purposes, such as filing Forms 3, 4, 5, and 144.

Sentiment

Score: 7

Explanation: The grant of shares to a director is generally a positive signal, indicating alignment of interests and potential confidence in future performance. The $0.00 price indicates a grant rather than a purchase, which is common for director compensation.

Positives

• A director receiving a grant of shares aligns their interests with shareholders, indicating confidence in the company's future performance.
• The increase in direct beneficial ownership by a director strengthens insider alignment.

Negatives

• The shares were acquired at $0.00, indicating a grant rather than an open market purchase, which might be viewed differently than a cash investment by an insider.

Risks

• The Limited Power of Attorney explicitly states that neither the Company nor any attorney-in-fact assumes liability for the undersigned's responsibility to comply with Exchange Act or Securities Act requirements, or for profit disgorgement under Section 16(b) of the Exchange Act. This highlights the individual's ultimate responsibility for compliance.

Future Outlook

The document does not provide specific forward-looking statements or guidance regarding the company's financial performance or strategic direction, focusing solely on an insider's equity transaction.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Corporate Governance

Related Party Transactions

• The acquisition of shares by a director (Mark A. Zorko) from the company (Nu Skin Enterprises, Inc.) constitutes a related party transaction, specifically an equity award as part of director compensation.

Stakeholder Impact

• Shareholders: The grant of shares to a director can be viewed positively as it aligns the director's financial interests with those of the shareholders, potentially motivating decisions that enhance shareholder value.

Key Dates

Recommendation

Keywords

Nu Skin Enterprises, NUS, Form 4, Insider Transaction, Stock Grant, Director Compensation, Beneficial Ownership, SEC Filing, Mark Zorko, Equity Award